Noxopharm Files Septic Shock Treatment Patent for Veyonda®
New indication doubles the commercial opportunity SYDNEY--(BUSINESS WIRE)--#Veyonda--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX)…
New indication doubles the commercial opportunity SYDNEY--(BUSINESS WIRE)--#Veyonda--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX)…
HOUSTON--(BUSINESS WIRE)--$NEXT #MoveTheWorldForward--NextDecade Corporation (NextDecade) (NASDAQ: NEXT) and Mitsubishi Heavy Industries America, Inc. (MHIA), part…
PITTSBURGH--(BUSINESS WIRE)--PPG (NYSE:PPG) today announced that it is extending the tender offer period for all…
Applying a Zero Trust and SASE Approach, Enterprises Accelerate WAN and Security Transformation, Advance Cloud…
SciNeuro Granted Exclusive Rights to Develop and Commercialize Alpha-synuclein Targeted Therapies in Greater China Alpha-synuclein…
DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Offshore Wind Turbine Market, Forecast to 2025 - Growth Impelled by Innovations…
TOKYO--(BUSINESS WIRE)--Japan National Tourism Organization (JNTO) launches a new Insider Guide to Japan, celebrating the…
LIBER V NEW Collection with fresh color variations and upgrades will be unveiled during this…
CFCA launches first commercial demo of LEI usage in digital certificates and becomes the first…
Cloud-first workforce engagement management platform chosen to enable market-leading Digital Services company to flow workforce…